deferasirox has been researched along with Inflammation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Argenziano, M; Di Paola, A; Marrapodi, MM; Rossi, F; Tortora, C | 1 |
| Abdelghany, AH; Ahmad, J; Almaimani, RA; Almasmoum, H; Azzeh, FS; BaSalamah, MA; El-Boshy, M; Elzubeir, ME; Ghaith, MM; Idris, S; Mahbub, AA; Refaat, B | 1 |
| Abbaszadeh, H; Mottaghi, S | 1 |
| Imoto, S; Kawano, S; Kono, M; Matsuhiroya, S; Obuchi, A; Saigo, K; Takahashi, T | 1 |
| Bardou-Jacquet, E; Beaumont-Epinette, MP; Ben Ali, Z; Brissot, P; Jouanolle, AM; Loreal, O | 1 |
| Alfonso, P; Andrade-Campos, M; Andreu, V; Gervas-Arruga, J; Giraldo, P; Irun, P; Medrano-Engay, B; Pocovi, M | 1 |
2 review(s) available for deferasirox and Inflammation
| Article | Year |
|---|---|
Emerging Roles of the Iron Chelators in Inflammation.
Topics: Animals; Benzoates; Deferasirox; Deferiprone; Deferoxamine; Inflammation; Iron; Iron Chelating Agents; Iron Overload; Mammals; Pyridones | 2022 |
Non-HFE hemochromatosis: pathophysiological and diagnostic aspects.
Topics: Alcohol Drinking; Benzoates; Biopsy; Cataract; Cation Transport Proteins; Decision Trees; Deferasirox; Diet; Gaucher Disease; Genetic Testing; Hemochromatosis; Hemochromatosis Protein; Hepcidins; Histocompatibility Antigens Class I; Humans; Inflammation; Iron; Iron Chelating Agents; Iron Metabolism Disorders; Iron Overload; Liver; Macrophage Activation Syndrome; Magnetic Resonance Imaging; Membrane Proteins; Metabolic Syndrome; Mutation; Phlebotomy; Receptors, Transferrin; Transferrin; Triazoles | 2014 |
1 trial(s) available for deferasirox and Inflammation
| Article | Year |
|---|---|
Grape seed extract in combination with deferasirox ameliorates iron overload, oxidative stress, inflammation, and liver dysfunction in beta thalassemia children.
Topics: beta-Thalassemia; C-Reactive Protein; Child; Deferasirox; Ferritins; Grape Seed Extract; Humans; Inflammation; Iron; Iron Overload; Liver Diseases; Oxidative Stress; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |
3 other study(ies) available for deferasirox and Inflammation
| Article | Year |
|---|---|
Deferasirox and vitamin D
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Caspase 3; Cholecalciferol; Deferasirox; Ferritins; Hepcidins; Hydrogen Peroxide; Inflammation; Interleukin-10; Interleukin-6; Iron; Iron Overload; Kidney; Low Density Lipoprotein Receptor-Related Protein-2; Male; Oxidative Stress; Rats; Receptors, Transferrin; Superoxide Dismutase-1; Tumor Necrosis Factor-alpha; Vitamin D; Vitamin D3 24-Hydroxylase | 2022 |
Deferasirox, an iron-chelating agent, alleviates acute lung inflammation by inhibiting neutrophil activation and extracellular trap formation.
Topics: Animals; Chelating Agents; Deferasirox; Extracellular Traps; Inflammation; Iron; Iron Chelating Agents; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; Neutrophil Activation; Neutrophils; Pneumonia | 2020 |
Iron homeostasis and infIammatory biomarker analysis in patients with type 1 Gaucher disease.
Topics: Adult; Aged; Benzoates; Biomarkers; Cytokines; Deferasirox; Deferoxamine; Female; Ferritins; Follow-Up Studies; Gaucher Disease; Hepcidins; Hexosaminidases; Homeostasis; Humans; Inflammation; Iron; Iron Chelating Agents; Iron Overload; Macrophage Activation; Macrophages; Male; Middle Aged; Quality of Life; Triazoles | 2014 |